Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea flag South Korea · Delayed Price · Currency is KRW
83,300
-100 (-0.12%)
Last updated: Jun 27, 2025

KRX:185750 Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Net Income
95,282109,073212,52180,95342,72091,633
Upgrade
Depreciation & Amortization
41,59839,77237,03033,59827,48223,786
Upgrade
Loss (Gain) From Sale of Assets
-137.99-154-111.88-54.05-119.34-68.18
Upgrade
Asset Writedown & Restructuring Costs
92.15985.36199.794,008--98.94
Upgrade
Loss (Gain) From Sale of Investments
3,3452,764-1,4652,77298.87-517.38
Upgrade
Loss (Gain) on Equity Investments
---798.36460.38603.47-
Upgrade
Provision & Write-off of Bad Debts
467.81637.26133.39996.56-533.19800.02
Upgrade
Other Operating Activities
-20,392-12,19040,96922,30010,34532,926
Upgrade
Change in Accounts Receivable
-18,5413,509-20,947-45,316-18,267-10,264
Upgrade
Change in Inventory
-135,337-114,342-5,980-54,466-53,771-46,240
Upgrade
Change in Accounts Payable
35,46114,41038,58415,824-15,59842,358
Upgrade
Change in Unearned Revenue
37.0318.551.140.16--1,099
Upgrade
Change in Other Net Operating Assets
10,64119,80618,0246,65819,942-28,892
Upgrade
Operating Cash Flow
12,51664,289318,16067,73412,904104,324
Upgrade
Operating Cash Flow Growth
-96.10%-79.79%369.72%424.92%-87.63%34.98%
Upgrade
Capital Expenditures
-31,538-38,474-41,218-44,898-48,243-32,639
Upgrade
Sale of Property, Plant & Equipment
213.24243.25451.58142.13142.4168.31
Upgrade
Sale (Purchase) of Intangibles
-28,645-27,483-27,588-8,166-3,591-4,178
Upgrade
Investment in Securities
106,15869,268-102,998-12,806-39,332-27,440
Upgrade
Other Investing Activities
176.46175.5539.75347.81213.96268.6
Upgrade
Investing Cash Flow
46,3653,731-171,313-65,380-90,809-63,921
Upgrade
Long-Term Debt Issued
-100,00032,000-101,59683,226
Upgrade
Long-Term Debt Repaid
--133,743-58,050-3,213-3,714-64,802
Upgrade
Net Debt Issued (Repaid)
-31,705-33,743-26,050-3,21397,88318,424
Upgrade
Repurchase of Common Stock
-13,927-16,008-6,025-1,888-1,935-2,078
Upgrade
Dividends Paid
-13,331-13,331-11,609-11,239-10,808-9,277
Upgrade
Other Financing Activities
-38.98-29.7-16.53--0-
Upgrade
Financing Cash Flow
-59,003-63,112-43,700-16,34085,1397,069
Upgrade
Foreign Exchange Rate Adjustments
1,3993,915-917.57-410.12920.1-734.87
Upgrade
Miscellaneous Cash Flow Adjustments
-0-----
Upgrade
Net Cash Flow
1,2778,824102,229-14,3968,15446,737
Upgrade
Free Cash Flow
-19,02225,815276,94222,836-35,33971,684
Upgrade
Free Cash Flow Growth
--90.68%1112.74%--29.27%
Upgrade
Free Cash Flow Margin
-1.17%1.63%16.59%1.53%-2.63%5.50%
Upgrade
Free Cash Flow Per Share
-1439.701948.9119821.041696.38-2578.755192.55
Upgrade
Cash Interest Paid
7,3927,6558,6316,4443,7583,637
Upgrade
Cash Income Tax Paid
39,01334,86811,81215,56151,68818,266
Upgrade
Levered Free Cash Flow
-115,139-75,307169,732-1,365-33,05359,644
Upgrade
Unlevered Free Cash Flow
-110,094-70,108175,5262,914-30,53462,064
Upgrade
Change in Net Working Capital
142,185106,087-53,17846,31065,4062,364
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.